Compound ID | 958
Ro 48-1256
Class: Beta-lactamase inhibitor (monobactam)
| Details of activity: | A bridged monobactam that inhibits class C β-lactamases with little antibacterial activity but greatly enhanced the combined Cephalosporins including ceftazidime and ceftriaxone |
| Institute where first reported: | Hoffmann-La Roche Inc, Switzerland |
| Year first mentioned: | 1995 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/274428150 |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.